" class="no-js "lang="en-US"> James Mackay Archives - Medtech Alert
Wednesday, February 08, 2023

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Aristea Therapeutics Announces Key Leadership Appointments to Advance its Clinical Pipeline

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]

Aristea Completes $63 Million Series B Financing to Accelerate Clinical Development of Novel Immunotherapy Drugs for the Treatment of Orphan Diseases

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]

  1. Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer Read more
  2. Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S. Read more
  3. Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth Read more
  4. Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer Read more
  5. TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials Read more